You are viewing a read-only archive of the Blogs.Harvard network. Learn more.

Alternative structure for trade and drug access

This article, by Tim Hubbard and James Love, argues that the TRIPs system of global patent protection encourages monopoly supply of HIV drugs.  Unlike a number of other analysts, they suggest that the system can be reformed to encourage competition, rather than suggesting we scrap it altogether.

Foreign Drugs Approved For Anti-AIDS Program

This Washington Post story of January 26 reports that the Bush Administration’s $15bn program to fight HIV in the developing world can now by inexpensive generic drugs from foreign companies rather than buy brand names. The FDA approved a package of generic drugs by Aspen Pharmacare of South Africa. There had been some concern that […]